01 1DARMERICA, LLC
01 1Rusalatide Acetate (TP508)
01 1U.S.A
NDC Package Code : 71052-075
Start Marketing Date : 2024-10-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
27
PharmaCompass offers a list of Rusalatide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Rusalatide Acetate manufacturer or Rusalatide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rusalatide Acetate manufacturer or Rusalatide Acetate supplier.
PharmaCompass also assists you with knowing the Rusalatide Acetate API Price utilized in the formulation of products. Rusalatide Acetate API Price is not always fixed or binding as the Rusalatide Acetate Price is obtained through a variety of data sources. The Rusalatide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Chrysalin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chrysalin, including repackagers and relabelers. The FDA regulates Chrysalin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chrysalin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Chrysalin supplier is an individual or a company that provides Chrysalin active pharmaceutical ingredient (API) or Chrysalin finished formulations upon request. The Chrysalin suppliers may include Chrysalin API manufacturers, exporters, distributors and traders.
click here to find a list of Chrysalin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chrysalin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chrysalin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chrysalin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chrysalin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chrysalin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chrysalin suppliers with NDC on PharmaCompass.
